Progressive Supranuclear Palsy
What's New
Last Posted: Nov 06, 2022
- Dementia risk variants - hunting needles in a haystack.
Oatman Stephanie R et al. Nature reviews. Neurology 2022 11 - Differential diagnosis between Parkinson's disease and atypical parkinsonism based on gait and postural instability: Artificial intelligence using an enhanced weight voting ensemble model.
Song Joomee et al. Parkinsonism & related disorders 2022 9832-37 - A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis.
Iwabuchi Yu et al. European journal of nuclear medicine and molecular imaging 2021 Jan - Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: A Machine Learning approach.
Vaccaro Maria Grazia et al. Journal of neuropsychology 2020 Nov - Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study
E Jones et al, Lancet Neurology, October 2020 - Using gait analysis' parameters to classify Parkinsonism: A data mining approach.
Ricciardi Carlo et al. Computer methods and programs in biomedicine 2019 Aug 180105033 - The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy.
Jabbari Edwin et al. Movement disorders : official journal of the Movement Disorder Society 2019 Jul - Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.
- Progressive supranuclear palsy
From NCATS Genetic and Rare Diseases Information Center - Progressive supranuclear palsy atypical
From NCATS Genetic and Rare Diseases Information Center
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: